AffyXell Therapeutics Revenue

Biotechnology Research • 338, Gwanggyojungang-ro, Korea, Republic of • 1-10 Employees

AffyXell Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at AffyXell Therapeutics

Shawn Park

CEO and President

Company overview

Headquarters	338, Gwanggyojungang-ro, Suji-gu, Building B-205, Woomi Newv Knowledge Industry Center, Yongin-si, Gyeonggi-do, KR
Phone number	+821198801693
Website	affyxell.com
NAICS	541714
Keywords	Orphan Diseases, Autoimmune Diseases, Stem Cell, Immune Disorders, Cell And Gene, Immunetolerance
Founded	2020
Employees	1-10
Socials

About AffyXell Therapeutics

AffyXell Therapeutics Co., Ltd. is a joint venture between Daewoong Pharmaceutical and Avacta Group, developing a novel cell & gene therapy to obstacle diseases that come from the imbalance of immune system homeostasis. AffyXell’s platform (also known as AFX) is created by converging the two proprietary technologies of its parent companies – Daewoong’s mesenchymal stem cell (MSC) and Avacta’s Affimer® platform. The immunomodulation function by MSC is further increased with the Affimer®, and the treatment developed by the AFX platform enhances restoring immunologic balance. AffyXell is developing pipelines taking this new therapeutic approach to lead in resolving fundamental causes of intractable diseases like immune rejection and autoimmune diseases.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

AffyXell Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore AffyXell Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-05-13	19	N/A

Funding Insights

Number of funding rounds

AffyXell Therapeutics Tech Stack

Discover the technologies and tools that power AffyXell Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Nginx

Reverse proxies

Frequently asked questions

AffyXell Therapeutics is located in 338, Gwanggyojungang-ro, KR.

You can reach AffyXell Therapeutics at +821198801693.

AffyXell Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

AffyXell Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

AffyXell Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

AffyXell Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at AffyXell Therapeutics

Shawn Park

CEO and President

4.8

40,000 users